Paloma Partners’s Bausch Health BHC Stock Holding History

Paloma Partners’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-69,400	Closed	-$2.08M	–	1281
2019 Q4	$2.08M	Buy	69,400 +19,500	+39%	+$507K	0.03%	573
2019 Q3	$1.09M	Buy	49,900 +38,000	+319%	+$869K	0.02%	698
2019 Q2	$300K	Sell	11,900 -31,100	-72%	-$738K	0.01%	1303
2019 Q1	$1.06M	Buy	43,000 +25,600	+147%	+$611K	0.03%	702
2018 Q4	$321K	Buy	+17,400	New	+$414K	0.01%	843
2018 Q2	–	Sell	-186,800	Closed	-$2.97M	–	1640
2018 Q1	$2.97M	Buy	+186,800	New	+$3.48M	0.05%	365
2016 Q4	–	Sell	-22,700	Closed	-$557K	–	1965
2016 Q3	$557K	Hold	22,700	–	–	0.01%	1355
2016 Q2	$457K	Buy	+22,700	New	+$643K	0.01%	1578
2015 Q2	–	Sell	-30,000	Closed	-$5.96M	–	1782
2015 Q1	$5.96M	Buy	30,000 +21,200	+241%	+$3.76M	0.17%	107
2014 Q4	$1.26M	Buy	+8,800	New	+$1.18M	0.05%	364

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Paloma Partners's BHC Position: Q2 2022 in Review

Paloma Partners sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 100 shares — an estimated $2K sold.

Paloma Partners first reported a position in BHC in Q2 2013 and held it in 23 quarters. The position peaked at $7.77M in Q2 2013. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

Paloma Partners reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
Paloma Partners sold 100 Bausch Health shares in Q2 2022, an estimated $2K.
Paloma Partners first reported a position in Bausch Health in Q2 2013 and held it in 23 quarters.
Paloma Partners's Bausch Health position peaked at $7.77M in Q2 2013.
327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.